> top > projects > sentences > docs > PubMed:9736046 > annotations
sentences Home  

PubMed:9736046 JSONTXT 7 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-106 Sentence denotes Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
T1 0-106 Sentence denotes Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
TextSentencer_T2 107-227 Sentence denotes MRP-1/CD9, KAI1/CD82, and ME491/CD63, have been reported to be associated with the metastatic potential of solid tumors.
T2 107-227 Sentence denotes MRP-1/CD9, KAI1/CD82, and ME491/CD63, have been reported to be associated with the metastatic potential of solid tumors.
TextSentencer_T3 228-371 Sentence denotes The aim of this study was to determine whether their expression in tumor tissues is a useful indicator for prognosis in breast cancer patients.
T3 228-371 Sentence denotes The aim of this study was to determine whether their expression in tumor tissues is a useful indicator for prognosis in breast cancer patients.
TextSentencer_T4 372-432 Sentence denotes We studied 109 breast cancer patients who underwent surgery.
T4 372-432 Sentence denotes We studied 109 breast cancer patients who underwent surgery.
TextSentencer_T5 433-559 Sentence denotes Quantitative reverse transcription-polymerase chain reaction analysis was performed to evaluate the expression of these genes.
T5 433-559 Sentence denotes Quantitative reverse transcription-polymerase chain reaction analysis was performed to evaluate the expression of these genes.
TextSentencer_T6 560-613 Sentence denotes The results were confirmed with immunohistochemistry.
T6 560-613 Sentence denotes The results were confirmed with immunohistochemistry.
TextSentencer_T7 614-661 Sentence denotes All of the carcinomas were ME491/CD63 positive.
T7 614-661 Sentence denotes All of the carcinomas were ME491/CD63 positive.
TextSentencer_T8 662-704 Sentence denotes Thirty-six tumors were MRP-1/CD9 negative.
T8 662-704 Sentence denotes Thirty-six tumors were MRP-1/CD9 negative.
TextSentencer_T9 705-934 Sentence denotes The disease-free survival rate and the 5-year survival rate of patients with MRP-1/CD9-negative tumors were both significantly lower than that in patients with MRP-1/ CD9-positive tumors (P = 0.0005 and P = 0.0380, respectively).
T9 705-934 Sentence denotes The disease-free survival rate and the 5-year survival rate of patients with MRP-1/CD9-negative tumors were both significantly lower than that in patients with MRP-1/ CD9-positive tumors (P = 0.0005 and P = 0.0380, respectively).
TextSentencer_T10 935-977 Sentence denotes Sixty-five tumors were KAI1/CD82 negative.
T10 935-977 Sentence denotes Sixty-five tumors were KAI1/CD82 negative.
TextSentencer_T11 978-1142 Sentence denotes The disease-free survival rate of patients with KAI1/CD82-negative tumors was significantly lower than that of patients with KAI1/CD82-positive tumors (P = 0.0065).
T11 978-1142 Sentence denotes The disease-free survival rate of patients with KAI1/CD82-negative tumors was significantly lower than that of patients with KAI1/CD82-positive tumors (P = 0.0065).
TextSentencer_T12 1143-1328 Sentence denotes Cox regression analysis demonstrated that MRP-1/CD9 status (P = 0.0016) and KAI1/CD82 status (P = 0.0234) were useful indicators for the disease-free survival of breast cancer patients.
T12 1143-1328 Sentence denotes Cox regression analysis demonstrated that MRP-1/CD9 status (P = 0.0016) and KAI1/CD82 status (P = 0.0234) were useful indicators for the disease-free survival of breast cancer patients.
TextSentencer_T13 1329-1576 Sentence denotes The disease-free survival rate and 5-year survival rate of patients with either MRP-1/CD9-negative or KAI1/CD82-negative tumors were both significantly lower than patients who were positive for both genes (P = 0.0003 and P = 0.0292, respectively).
T13 1329-1576 Sentence denotes The disease-free survival rate and 5-year survival rate of patients with either MRP-1/CD9-negative or KAI1/CD82-negative tumors were both significantly lower than patients who were positive for both genes (P = 0.0003 and P = 0.0292, respectively).
TextSentencer_T14 1577-1693 Sentence denotes The expression of MRP-1/CD9 and KAI1/CD82 genes are useful indicators of a poor prognosis in breast cancer patients.
T14 1577-1693 Sentence denotes The expression of MRP-1/CD9 and KAI1/CD82 genes are useful indicators of a poor prognosis in breast cancer patients.